Overview

MK0476 Study in Adult Patients With Allergic Rhinitis (0476-378)

Status:
Completed
Trial end date:
2004-03-01
Target enrollment:
Participant gender:
Summary
The clinical study evaluates the efficacy and safety of MK0476 in adult patients with allergic rhinitis.
Phase:
Phase 2
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Montelukast